Where can I read the original reporting?

Kodawire links to 1 source for this story.

Bias Comparison — Nektar Therapeutics stock rises on $90M jury verdict vs Lilly

Media Spectrum

Total: 1 source•Published: 16m ago•Last Updated: 2m ago

0%100%0%

LeftCenterRight

Left-leaning

Coverage Gap

Unreported by left-leaning outlets. Coverage is currently concentrated on other perspectives.

0 sources

Center

100% of coverage

I

Investing.com

Nektar Therapeutics stock rises on $90M jury verdict vs Lilly

View all 1 sources

Right-leaning

Coverage Gap

Unreported by right-leaning outlets. Coverage is currently concentrated on other perspectives.

0 sources

Bias & Framing Analysis

Top Framing Differences

Left: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.
Center: Nektar Therapeutics stock rises on $90M jury verdict vs Lilly
Right: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.

Overall Tone

Center

Coverage Blindspots

Left

Coverage blindspot: Reporting on this development is currently concentrated in other segments of the media landscape.

Right

Coverage blindspot: Reporting on this development is currently concentrated in other segments of the media landscape.

Credibility & Editorial Standards

Story FramingCenter

Evaluated across 1 reporting source (0% Left · 100% Center · 0% Right)

L 0%C 100%R 0%

Outlet ConsensusCenter

Historical editorial baseline for Investing.com

BusinessCenter

Politics & GovernanceCenter

Credibility ScoreHigh Credibility

89/ 100

Multi-factor accuracy index for Investing.com and related desks based on verifiable sourcing and editorial standards.

Factuality: High 100%

Ownership: Investing.com (Corporate)

Timeline of this story

14m agoInvesting.com: Nektar Therapeutics stock rises on $90M jury verdict vs Lilly

Historical Context

2024 — Global Monetary Easing

Central banks pivot from multi-decade rate hikes to targeted easing cycles.

2023 — Regional Bank Liquidity Crisis

Rapid digital runs prompt emergency deposit backstops and tighter capital oversight.

2022 — Commodity Shocks & Reshoring

Supply disruption accelerates corporate nearshoring and friend-shoring investments.

Posts on X

Public conversation related to this story

Microsoft has launched a new version of its Copilot app that puts AI chat, coding and long-running agents in one place for work. Jared Spataro, its chief marketing officer for AI at Work, announced it in a blog post on Friday. Chief executive Satya Nadella first promised a Copilot super app at the Build conference […] This story continues at The Next Web

L 0%C 100%R 0%

1 sources • 1

Bath & Body Works: $10 off a $40 Purchase!

Multiple outlets • 1h ago

Heading to Bath & Body Works soon? Check out this coupon! Today only, Bath & Body Works is offering $10 off a $40 purchase when you use the promo code SOAR at checkout! This is a great time to stock up on gifts and fall items. Choose free in-store pickup to avoid shipping costs.

L 0%C 100%R 0%

1 sources • 1

HSBC upgrades Synopsys stock rating to buy on AI growth outlook

Multiple outlets • 1h ago

HSBC upgrades Synopsys stock rating to buy on AI growth outlook

L 0%C 100%R 0%

1 sources • 1

Reader Discussion

Loading comments…

Nektar Therapeutics stock rises on $90M jury verdict vs Lilly